Description
This blend is a research material intended for controlled laboratory settings where both constituents are used in combination. Each component is individually characterized prior to blending; lot documentation reflects the source materials.
Note that the two components differ substantially in molecular weight — roughly 1,420 versus 889 g/mol — so equal mass loading does not correspond to equal molar quantity. On a molar basis a 10 mg/10 mg blend is approximately 1.6:1 in favor of TB-500. TB-500 here is the Ac-LKKTETQ heptapeptide fragment (889 g/mol), not full-length thymosin β4.
Documentation such as COA, HPLC chromatograms, and LC-MS data may be available on a lot basis where applicable. Request documentation by emailing connect@novuspeptides.com with the catalog number and required tests.
This product is sold strictly for laboratory research use only and is not intended for human or veterinary administration. Buyer is responsible for lawful handling, storage, and use in accordance with all applicable regulations.
Technical Summary
- Catalog #:BPC-157/TB-500
- Form:Lyophilized Powder (10 mg / 10 mg)
- Purity:≥ 99%
- Verification:HPLC / LC-MS
- CAS Number:Mixture — see components
- Molecular Weight:Mixture — see components
- Molecular Formula:Mixture — see components
- Component 1 — BPC-157:10 mg · CAS 137525-51-0 · C62H98N16O22 · 1419.55 g/mol · 15 aa (GEPPPGKPADDAGLV)
- Component 2 — TB-500:10 mg · CAS 885340-08-9 · C38H68N10O14 · 889.01 g/mol · Ac-LKKTETQ (Tβ4 fragment 17-23)
- Appearance:White Lyophilized Powder
